Searchable abstracts of presentations at key conferences in endocrinology

ea0063p756 | Thyroid 2 | ECE2019

Systematic review and meta-analysis of occurrence of other autoimmune diseases in autoimmune polyglandular syndrome type II and type III

Pham-Dobor Greta , Bajnok Laszlo , Gergics Marin , Hanak Lilla , Hegyi Peter , Marta Katalin , Mezősi Emese

Introduction: The autoimmune polyglandular syndrome (APS) is a complex, heterogeneous condition in which autoimmune diseases (AIs) of endocrine and non-endocrine organs can occur. There are four subgroups. The majority of patients are categorized as having APS II or APS III. In APS II, patients have Addison’s disease (AD) and autoimmune thyroid diseases (AITDs) or type I. diabetes mellitus (T1DM), while in the APS III, AITDs are combined with other autoimmune illnesses ex...

ea0037gp.27.08 | Thyroid – hyperthyroidism and treatment | ECE2015

There is a detectable immune activity in the orbits of all patients diagnosed with Graves' disease regardless of later development of Graves' orbitopathy

Berta Eszter , Ujhelyi Bernadett , Szabados Lajos , Galuska Laszlo , Erdei Annamaria , Gazdag Annamaria , Halmi Sandor , Nagy Endre , Bodor Miklos

Graves’ orbitopathy (GO) is a common complication of Graves’ disease (GD) which is often responding poorly to therapy. GO may develop before or together with, or during the course of GD. In an individual patient, the development of GO cannot be predicted. We assumed that orbital autoimmune activity is predictable using orbital 99mTc-labelled diethylenetriamine pentaacetic acid (99mTc-DTPA) SPECT. We aimed to determine whether any orbital autoimmune activity can be id...

ea0032p1019 | Thyroid (non-cancer) | ECE2013

Differential item functioning of the thyroid-specific quality of life questionnaire ThyPRO

Watt Torquil , Hegedus Laszlo , Bonnema Steen Joop , Bjorner Jakob Bue , Groenvold Mogens , Rasmussen Ase Krogh , Feldt-Rasmussen Ulla

Objective: Thyroid diseases have been shown to affect quality of life. A thyroid-specific patient-reported outcome (PRO) measuring quality of life, the ThyPRO, has recently been developed and validated using classical clinic- and psycho-metric methods. The purpose of the present study was to apply modern psychometrics to validate the measure as the extent of differential item functioning (DIF) according to sex, age, education and diagnosis, within the ThyPRO.<p class="abst...

ea0026p342 | Obesity | ECE2011

Monitoring the efficacy of long term low intensity physical exercise programmes by the laboratory and hormone profile of obesity

Berko A M , Kis G K , Szablics P , Kiss B , Orban K , Seres E , Varga Cs , Laszlo F

Introduction: In the human, obesity is one of the leading health problems as declared by the World Health Organization. Obesity is frequently associated with diabetes, hypertension and hyperlipaemia, these acts together as metabolic syndrome (MS). The risk of cardiovascular diseases is 5 to 10 times higher in MS. Lack of daily exercise is a good reason to evolve MS. Several hormones take part in the development of MS. Leptin and insulin, which are produced by the adipose tissu...

ea0016p584 | Paediatric endocrinology | ECE2008

Growth hormone deficient children born small-for-gestational-age need higher than replacement dose of hGH for successful treatment

Peter Ferenc , Luczay Andrea , Solyom Eniko , Gellen Balazs , Niederland Tamas , Felszeghy Eniko , Sagodi Laszlo , Solyom Janos , Muzsnai Agota

Growth hormone deficient (GHD) children born small-for-gestational-age (SGA) receive the same hGH dose as the children born with appropriate weight/length for gestational age (AGA). There are very few data on their lower growth response to the usual GH replacement dose. The aim of this multi-centre retrospective study is to analyse the hGH dose dependency of GHD children with SGA.SGA was defined as a birth weight/length below – 2 SD for gestational ...

ea0016p676 | Steroid receptors | ECE2008

Glucocorticoid receptor gene polymorphisms in patients with Cushing's disease and adrenal Cushing's syndrome

Szappanos Agnes , Patocs Attila , Toke Judit , Sereg Marta , Futo Laszlo , Kende Zoltan , Varga Ibolya , Glaz Edit , Racz Karoly , Toth Miklos

Introduction: The hypothalamic–pituitary–adrenal axis setpoint and the glucocorticoid sensitivity in various tissues are at least partly genetically determined. The glucocorticoid receptor (GR) gene polymorphisms may have an impact on the development and/or the variability of clinical manifestations of endogenous hypercortisolism, however their role has not been investigated in patients with endogenous hypercortisolism.Methods: We investigated ...

ea0014p135 | (1) | ECE2007

Papillary thyroid cancer – the possible role of death ligands in tumor immunology

Mezosi Emese , Gyory Ferenc , Borbely Agnes , Ujhelyi Bernadett , Soos Gyorgyike , Nagy Endre V. , Varga Zsuzsa , Bajnok Laszlo

Papillary thyroid cancer (PTC) cells and immune cells can kill each other by death ligands. Death ligands induce apoptosis only in sensitive cells. The sensitivity to apoptosis is regulated in a complex and poorly understood manner. The aim of this study was to investigate the Fas ligand (FasL) and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) expression in PTC cells and tumor infiltrating immune cells. Twenty-six PTCs without and fifteen PTCs with cervical l...

ea0014p360 | (1) | ECE2007

Do patients and clinicians agree about which aspects of quality of life are relevant when evaluating the impact of thyroid diseases?

Watt Torquil , Hegedüs Laszlo , Rasmussen Æse Krogh , Groenvold Mogens , Bonnema Steen Joop , Bjorner Jakob , Feldt-Rasmussen Ulla

Objective: During the development of a thyroid-specific quality of life (QoL) questionnaire, patients and clinicians rated the relative relevance of a list of possibly relevant QoL issues. In this study we compare the patient and clinician ratings.Methods: Fifteen thyroid experts and 80 thyroid outpatients (14 with non-toxic goitre, 12 nodular toxic goitre, 21 Graves’ disease, 17 thyroid associated ophthalmopathy (TAO) and 16 primary hypothyroidism)...

ea0014p479 | (1) | ECE2007

Pituitary insufficiency after traumatic brain injury in southwest Hungary

Nemes Orsolya , Nagy Zsuzsanna , Bodis Beata , Bajnok Laszlo , Szellar Dora , Czeiter Endre , Buki Andras , Doczi Tamas , Mezosi Emese

Traumatic brain injury (TBI) often results in long-term pituitary insufficiency. Regular endocrine screening of TBI patients is advised after the acute phase of the treatment period. We monitored pituitary functions in 32 TBI patients (28 men, 4 women). Endocrine tests were performed from 3 to 36 months after the brain injury. Thyroid functions, cortisol and ACTH levels, prolactin, sex hormone concentrations, GH/IGF1 axis and posterior pituitary function were evaluated. Additi...

ea0056p675 | Nuclear receptors and Signal transduction | ECE2018

Inactive AT1 angiotensin receptor acts as a signaling hub: a novel mechanism of receptor cross-talk

Toth Andras D , Prokop Susanne , Gyombolai Pal , Varnai Peter , Gurevich Vsevolod V , Turu Gabor , Balla Andras , Hunyady Laszlo

It is generally believed that the signal transduction of AT1 angiotensin receptor (AT1R), the major receptor of angiotensin II, requires ligand binding and subsequent adoption of its active conformation. Activated AT1R induces a plethora of signaling pathways, in contrast to inactive AT1R, which was thought to be silent in terms of signaling. We hypothesized that unliganded, but phosphorylated AT1R may recruit β-arrestins, the key proteins of receptor desensitization, int...